Literature DB >> 16432235

Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.

Shunyou Wang1, Alejandro J Garcia, Michelle Wu, Devon A Lawson, Owen N Witte, Hong Wu.   

Abstract

PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a potent tumor suppressor gene frequently mutated in human prostate cancers. Deletion of Pten in a murine model of prostate cancer recapitulates the disease progression seen in humans. Using defined cell lineage markers, we demonstrate that PTEN negatively regulates p63-positive prostatic basal cell proliferation without blocking differentiation. Concomitant with basal cell proliferation is the expansion of a prostate stem/progenitor-like subpopulation as evidenced by the progressive increase of stem cell antigen-1 (Sca-1)- and BCL-2-positive cells. This observation provides strong evidence that basal cell proliferation can be an initiating event for precancerous lesions. Sca-1(+) and BCL-2(+) progenitors may serve as cancer-initiating cells in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432235      PMCID: PMC1345717          DOI: 10.1073/pnas.0510652103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Germline stem cells anchored by adherens junctions in the Drosophila ovary niches.

Authors:  Xiaoqing Song; Chun-Hong Zhu; Chuong Doan; Ting Xie
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

2.  Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells.

Authors:  Chau P Tran; Connie Lin; Joyce Yamashiro; Robert E Reiter
Journal:  Mol Cancer Res       Date:  2002-12       Impact factor: 5.852

Review 3.  Focus on prostate cancer.

Authors:  William Isaacs; Angelo De Marzo; William G Nelson
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

4.  Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Authors:  Rajal B Shah; Ming Zhou; Michele LeBlanc; Matthew Snyder; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

5.  PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry.

Authors:  Matthias Groszer; Rebecca Erickson; Deirdre D Scripture-Adams; Joseph D Dougherty; Janel Le Belle; Jerome A Zack; Daniel H Geschwind; Xin Liu; Harley I Kornblum; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

6.  p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.

Authors:  J K Parsons; W R Gage; W G Nelson; A M De Marzo
Journal:  Urology       Date:  2001-10       Impact factor: 2.649

Review 7.  The development of androgen-independent prostate cancer.

Authors:  B J Feldman; D Feldman
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

8.  Cell differentiation lineage in the prostate.

Authors:  Y Wang; S Hayward; M Cao; K Thayer; G Cunha
Journal:  Differentiation       Date:  2001-10       Impact factor: 3.880

9.  DE-cadherin-mediated cell adhesion is essential for maintaining somatic stem cells in the Drosophila ovary.

Authors:  Xiaoqing Song; Ting Xie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-22       Impact factor: 11.205

10.  Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis.

Authors:  Akira Tsujimura; Yasuhiro Koikawa; Sarah Salm; Tetsuya Takao; Sandra Coetzee; David Moscatelli; Ellen Shapiro; Herbert Lepor; Tung-Tien Sun; E Lynette Wilson
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

View more
  148 in total

1.  ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization.

Authors:  M K Leonard; R Kommagani; V Payal; L D Mayo; H N Shamma; M P Kadakia
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Development of a peptide-drug conjugate for prostate cancer therapy.

Authors:  Wanyi Tai; Ravi S Shukla; Bin Qin; Benyi Li; Kun Cheng
Journal:  Mol Pharm       Date:  2011-05-03       Impact factor: 4.939

Review 3.  Prostate cancer stem cell biology.

Authors:  C Yu; Z Yao; Y Jiang; E T Keller
Journal:  Minerva Urol Nefrol       Date:  2012-03       Impact factor: 3.720

4.  Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice.

Authors:  Hong Shen-Li; Susan Koujak; Matthias Szablocs; Ramon Parsons
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

Review 5.  The androgen receptor and stem cell pathways in prostate and bladder cancers (review).

Authors:  Katarzyna Marcinkiewicz; Kymora B Scotland; Stephen A Boorjian; Emeli M Nilsson; Jenny Liao Persson; Per Anders Abrahamsson; Cinzia Allegrucci; Ieuan A Hughes; Lorraine J Gudas; Nigel P Mongan
Journal:  Int J Oncol       Date:  2011-09-28       Impact factor: 5.650

6.  SLUG is a direct transcriptional repressor of PTEN tumor suppressor.

Authors:  Berna Uygur; Katrina Abramo; Evgenia Leikina; Calvin Vary; Lucy Liaw; Wen-Shu Wu
Journal:  Prostate       Date:  2015-03-01       Impact factor: 4.104

7.  Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.

Authors:  Ntube N O Ngalame; Erik J Tokar; Rachel J Person; Yuanyuan Xu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

Review 8.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

9.  Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.

Authors:  Yuzhi Yin; Hongyan Yuan; Xiao Zeng; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 10.  Exploring the origins of the normal prostate and prostate cancer stem cell.

Authors:  Susan Kasper
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.